ABOUT LDN-27219 DRUG DEVELOPMENT PIPELINE

About LDN-27219 drug development pipeline

Consensus sequence for tTG crosslinking substrates. Alignment of all glutamine-donor crosslinking substrates explained in the Transdab databases demonstrates that in addition to glutamine (Q at posture 0), there is little to no favoritism for various residues at up to five positions just before or after the glutamine residue to be crosslinked. Dete

read more